Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
444.00Prev. Close
446.45Volume
94,028Total traded value
4.16 CrUpper Circuit
531.35Lower Circuit
354.25Fundamentals
| Market Cap | ₹1,398Cr |
| ROE | 10.52% |
| P/E Ratio(TTM) | 30.50 |
| EPS(TTM) | 14.51 |
| P/B Ratio | 2.87 |
| Dividend Yield | 0.23% |
| Industry P/E | 39.94 |
| Book Value | 154.00 |
| Debt to Equity | 0.49 |
| Face Value | 5 |
Understand Fundamentals
Financials
About Bajaj Healthcare
Bajaj Healthcare is a vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients (APIs), intermediates, finished dosage forms, and nutraceuticals for quality-conscious customers. The company's vision is to become a leading pharmaceutical player in India and a significant competitor globally by providing high-quality, affordable products. It is recognized as the world's largest manufacturer of Chlorhexidine base and India's largest manufacturer of Ascorbic Acid.;
| Parent Organisation | Bajaj Healthcare |
| Managing Director | Mr. Anil Jain |
| NSE Symbol | BAJAJHCARE |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 82.27 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.89 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.53 | ||
| Wockhardt | NA (0.00%) | -426.40 |